Mineralys Therapeutics, Inc. (MLYS)
24.07
+0.79
(+3.39%)
USD |
NASDAQ |
Mar 20, 16:00
24.06
-0.01
(-0.04%)
After-Hours: 20:00
Mineralys Therapeutics Total Liabilities (Quarterly) : 15.11M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.526B |
| Nektar Therapeutics | 190.57M |
| Syndax Pharmaceuticals, Inc. | 465.08M |
| Cogent Biosciences, Inc. | 301.24M |
| Lyell Immunopharma, Inc. | 91.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 661.81M |
| Shareholders Equity (Quarterly) | 646.69M |
| Current Ratio | 43.76 |